KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
75 hedge funds and large institutions have $221M invested in Kindred Biosciences, Inc. in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
–
Holders Change %
0%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
29
Reduced
18
Closed
12
Calls
$1.17M
Puts
–
Net Calls
+$1.17M
Net Calls Change
+$735K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$15.8M |
| 2 |
2
BlackRock
New York
|
$19.9M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$3.53M |
| 4 |
AI
4
Ariel Investments
Chicago,
Illinois
|
$23.7M |
| 5 |
RCMNY
5
Rubric Capital Management (New York)
New York
|
$2.5M |
